After their antitrust-fighting colleagues levied $251 million in fines against Swiss drugmakers Roche and Novartis on allegations that they colluded to protect sales of their eye drug, Italian prosecutors are now investigating possible market...
Novartis AG (NVS)
34th Cowen and Company Healthcare Conference Call
March 3, 2014 2:50 PM ET
David Epstein – Division Head, Novartis Pharmaceuticals
Good afternoon. I would...
By Donald van Deventer:
Novartis A.G. (NVS) is one of the world's leading pharmaceutical companies. Like any iconic brand name, equity analysts have strong opinions on the stock, both positive and negative. On February 28, 2014, the bonds of...
When outgoing Lufthansa chief executive Christoph Franz takes over as chairman of Swiss drugmaker Roche on Tuesday, it could be the start of a new era of less-frosty relations with arch-rival Novartis .
Swiss pharma group Novartis (NOVN.VX) will work more closely with rival Roche (ROG.VX) but rules out a merger, its chairman said in a newspaper interview on Sunday. Asked whether the two companies wanted to stay independent, Joerg Reinhardt, who...
Oops! Unable to complete your request. Please refresh your browser.